Neutra Corp. (NTRR) stock
NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Neutra shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Neutra's shares outstanding was 1.64B at Oct 31, 2021. For fiscal 2021 it was 1.19B, up 393.9% from the year before. The highest annual figure on record is 1.19B in fiscal 2021.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Jan 31, 2021 | 1.19B | +393.9% |
| FY2020 | Jan 31, 2020 | 242M | +1520.3% |
| FY2019 | Jan 31, 2019 | 15M | +183.3% |
| FY2018 | Jan 31, 2018 | 5M | +145.9% |
| FY2017 | Jan 31, 2017 | 2M | +85.4% |
| FY2016 | Jan 31, 2016 | 1M | +104.7% |
| FY2015 | Jan 31, 2015 | 1M | +192.6% |
| FY2014 | Jan 31, 2014 | 0M | +311.8% |
| FY2013 | Jan 31, 2013 | 0M | +325.2% |
| FY2012 | Jan 31, 2012 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | 1.64B | +66.4% |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | 1.52B | +122.1% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | 1.50B | +403.3% |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | 801M | +772.5% |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | 984M | +2620.2% |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | 685M | +4864.1% |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | 299M | +4059.9% |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | 92M | +1240.2% |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | 36M | +466.7% |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | 14M | +122.6% |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | 7M | +48.3% |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | 7M | +91.5% |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | 6M | +139.4% |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | 6M | +185.1% |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | 5M | +148.0% |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | 4M | +103.1% |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | 3M | +82.3% |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | 2M | +85.0% |
| Q2 FY2017CQ2 2016 | Jul 31, 2016 | 2M | +86.9% |
| Q1 FY2017CQ1 2016 | Apr 30, 2016 | 2M | +89.4% |
| Q4 FY2016CQ4 2015 | Jan 31, 2016 | 1M | +80.9% |
| Q3 FY2016CQ3 2015 | Oct 31, 2015 | 1M | +88.9% |
| Q2 FY2016CQ2 2015 | Jul 31, 2015 | 1M | +124.5% |
| Q1 FY2016CQ1 2015 | Apr 30, 2015 | 1M | +163.9% |
| Q4 FY2015CQ4 2014 | Jan 31, 2015 | 1M | +212.4% |
| Q3 FY2015CQ3 2014 | Oct 31, 2014 | 1M | – |
| Q2 FY2015CQ2 2014 | Jul 31, 2014 | 0M | – |
| Q1 FY2015CQ1 2014 | Apr 30, 2014 | 0M | – |
| Q4 FY2014CQ4 2013 | Jan 31, 2014 | 0M | – |
See a number that looks wrong?